Literature DB >> 30545639

Asxl1 ablation in mouse embryonic stem cells impairs neural differentiation without affecting self-renewal.

SoJung An1, Ui-Hyun Park1, Seungtae Moon1, Myengmo Kang1, Hyesook Youn1, Jin-Taek Hwang2, Eun-Joo Kim3, Soo-Jong Um4.   

Abstract

Additional sex comb-like1 (Asxl1) is known as a chromatin modulator that plays dual functions in transcriptional regulation depending on the cell type. Recent studies using Asxl1 knockout mice revealed that Asxl1 is important for the proliferation and differentiation of hematopoietic progenitor cells, and the development of organs. Although we previously reported Asxl1 as a Sox2 target gene, its function in embryonic stem cells (ESCs) remains largely unknown. For this purpose, we isolated ESCs from the blastocyst inner cell mass of Asxl1-/- mice. Asxl1 deficiency in ESCs exhibited no effect on cell proliferation, expression of core pluripotent transcription factors, or alkaline phosphatase activity, suggesting dispensability of Asxl1 for self-renewal of ESCs. By contrast, the differentiation of Asxl1-/- ESCs was significantly affected as shown by size reductions of embryoid bodies accompanied with apoptosis, aberrant expression of differentiation genes, downregulation of bivalent neurogenesis genes, and abnormal axon formation in neurons. Overall, our findings indicated that Asxl1 played a critical role in regulating genes associated with neural differentiation without affecting self-renewal of mouse ESCs.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Asxl1; Embryonic stem cells; Knockout; Neurogenesis; Self-renewal

Mesh:

Substances:

Year:  2018        PMID: 30545639     DOI: 10.1016/j.bbrc.2018.12.047

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  1 in total

1.  Hcfc1a regulates neural precursor proliferation and asxl1 expression in the developing brain.

Authors:  Victoria L Castro; Joel F Reyes; Nayeli G Reyes-Nava; David Paz; Anita M Quintana
Journal:  BMC Neurosci       Date:  2020-06-10       Impact factor: 3.288

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.